Share delivers predictive biomarkers as a basis for decision support in precision medicine. They use novel, state of the art, machine learning approaches specifically designed to find complex patterns in biomedical data.

Focus: Genomics-focused drug discovery platform 

Team: Joern Klinger (CEO) and Marco Schmidt (CSO)


Be part of SBC Catalyser Programme!

Spaces are limited to a maximum of 10 companies per cohort. Contact Marco to know more or to apply.

Contact Marco

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.